本季度信息
根据公告披露,微创医疗持股40.32%的上海微创心脉医疗科技(集团)股份有限公司(以下简称“心脉医疗科技”)于2026年第一财季实现营收3.70亿元,同比增长11.45%;经调整净利润1.55亿元,同比增长19.44%。公告显示,这部分业绩在微创医疗的财务报表中得到并表处理。
业务分项
本期财报仅披露了心脉医疗科技的营收及利润数据,公告未进一步细分业务板块具体经营表现。
本季度信息
根据公告披露,微创医疗持股40.32%的上海微创心脉医疗科技(集团)股份有限公司(以下简称“心脉医疗科技”)于2026年第一财季实现营收3.70亿元,同比增长11.45%;经调整净利润1.55亿元,同比增长19.44%。公告显示,这部分业绩在微创医疗的财务报表中得到并表处理。
业务分项
本期财报仅披露了心脉医疗科技的营收及利润数据,公告未进一步细分业务板块具体经营表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.